Emerging Growth Opportunities for Enterprise Imaging Partnerships in Selected Asia-Pacific Countries
New business models overcome budget restrictions to enable equipment purchase and management
Click image to view it in full size
Medical imaging original equipment manufacturers (OEMs) are increasingly marketing innovative customer engagement models which enable revenue growth while also helping OEMs reduce overall customer acquisition costs. These engagement models comprise long-term partnerships between OEMs and healthcare providers, such as integrated delivery networks, whereby the healthcare provider is able to purchase imaging equipment under an opex arrangement (monthly recurring charges), as opposed to forking over large, upfront cash outlays. Another key component of these engagement models is the shared responsibility and risk borne by the OEM whereby a portion of the OEMs remuneration is tied to the provider realizing certain operational and clinical outcomes. From a provider standpoint, such long-term partnerships offer tremendous financial/budgetary flexibility by allowing them to modernize imaging equipment despite facing budgetary constraints. Apart from healthcare providers, such opex-based imaging equipment procurement models also carry substantial appeal for independent imaging centers that may be seeking to expand their services portfolio to include more complex diagnostic imaging such as high-end magnetic resonance imaging (MRI) or more sophisticated computed tomography (CT). Going forward, interest in such solutions is likely to continue to gain steam within the APAC market, both public and private healthcare provider entities as these arrangements have the potential to significantly expand access to modern diagnostics technology without overburdening provider finances.
Frost & Sullivan’s research analyzes the impact of long-term partnerships on medical imaging OEM and healthcare provider outcomes. Moreover, the study highlights an analysis of several such partnerships, their scope, and overall financial impact. In addition, the research covers several APAC countries such as India, Australia, Malaysia, Singapore, and others. Revenue-based market share is also provided for major medical imaging OEMs.
Take your first step towards achieving growth-centric solutions with our
Growth Pipeline Dialog™. Speak to our industry experts in a complimentary open discussion that will spark innovative thinking and growth opportunities that will benefit your organization.